Effect of manufacturing procedures on the dissolution and human bioavailability of diphenylhydantoin.
Authors:
- Shigeru YakouSYShigeru Yakou
- Yaeko YajimaYYYaeko Yajima
- Takashi SonobeTSTakashi Sonobe
- Masayasu SugiharaMSMasayasu Sugihara
- Yukio FukuyamaYFYukio Fukuyama
- 1 January 1982
- journal article
- research article
- Published by Pharmaceutical Society of Japan in Chemical and Pharmaceutical Bulletin
- Vol. 30 (1) , 319-325
Abstract
The dissolution characteristics of commercial diphenylhydantoin (DPH) crystals, freeze-dried DPH, 20% simple blend DPH powder, and 20% solvent deposition DPH powder were determined by the use of a USP dissolution test apparatus in pH 1.2 and pH 7.5 test media. The solvent deposition method was found to give DPH with the fastest dissolution rate probably due to improvement in the wettability of the crystals as well as decrease in the particle size. Content uniformity was assessed and accelerated testing of the preparations was also performed to explore optimum formulations. No conversion of the crystal form of DPH or freeze-dried DPH was detected through powder X-ray diffractometry and IR spectrometry under the accelerated storage conditions. Based on the results of the above in vitro studies, 20% DPH solvent deposition powder and the DPH crystals (as a reference) were selected for a bioavailability study in humans. A cross over study in 6 healthy male volunteers revealed the existence of a critical particle size for satisfactory bioavailability. Other factors, such as the use of diluents, also substantially affect the bioavailability of a DPH preparation, even though the crystals used to prepare the finished product were all from the same batch. These results have important implications for manufacturing procedures for DPH preparations.Keywords
This publication has 6 references indexed in Scilit:
- In Vitro and In Vivo Availability of Hydrophilized Phenytoin from CapsulesJournal of Pharmaceutical Sciences, 1979
- Dissolution behaviors and gastrointestinal absorption of phenytoin in phenytoin-polyvinylpyrrolidone coprecipitate.Chemical and Pharmaceutical Bulletin, 1978
- Solubility and Ionization Characteristics of PhenytoinJournal of Pharmaceutical Sciences, 1977
- Bioavailability of 11 phenytoin productsJournal of Pharmacokinetics and Biopharmaceutics, 1977
- FACTORS AFFECTING BIOAVAILABILITY OF PHENYTOIN1977
- Dissolution Behavior and Bioavailability of Phenytoin from a Ground Mixture with Microcrystalline CelluloseJournal of Pharmaceutical Sciences, 1976